In the News
ADA issues updated position statement on hypertension and diabetes
The statement updates the ADA's 2003 position statement on this topic and summarizes clinical trials of intensive hypertension treatment strategies.
Analyses from SPRINT examine cost-effectiveness, patient-reported outcomes with intensive BP control
The first analysis used a microsimulation model to apply findings from SPRINT to a hypothetical cohort of eligible patients. The second compared patient-reported outcomes from SPRINT in the intensive versus the standard treatment group.
Short-term oral corticosteroids no better than placebo at treating lower respiratory tract infection symptoms, study finds
Researchers randomized 199 patients to receive two 20-mg prednisolone tablets and 202 patients to receive placebo once daily for five days, with primary outcomes of duration of moderately bad or worse cough and mean symptom severity on days two and four.
MKSAP quiz: 2-week history of rash on face, midchest
This week's quiz asks readers to determine the most likely diagnosis for a 32-year-old man evaluated for a 2-week history of a rash on his face and midchest consisting of small, reddish, intensely itchy “lumps.”
Shingles vaccine can be given before starting tofacitinib, industry-funded study says
The authors concluded that tofacitinib alone for the treatment of rheumatoid arthritis should be considered to help reduce the risk of shingles in vaccinated patients, provided that patients' arthritis remains controlled on the drug.
Improving physician satisfaction by eliminating unnecessary practice burdens
Yul Ejnes, MD, MACP, continues his monthly column at KevinMD, discussing burdens on physician practices.
Vote for your favorite entry
ACP Internist Weekly's cartoon caption contest continues. Readers can vote for their favorite caption to determine the winner.